Promacta and Tenormin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promacta (eltrombopag olamine) and Tenormin (atenolol). Common drug interactions include bone marrow plasmacyte count increased among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Promacta and Tenormin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Promacta?

Promacta has active ingredients of eltrombopag olamine. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,758 Promacta users. Check the latest studies of Promacta.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,474 Tenormin users. Check the latest studies of Tenormin.

On Jul, 14, 2026

11 people who take Promacta and Tenormin together, and have interactions are studied.

Promacta and Tenormin drug interactions.

What are the common drug interactions of Promacta and Tenormin, by gender? *:

female:

Bone marrow plasmacyte count increased
Bone marrow reticulin fibrosis (thickening and scarring of bone marrow reticulin)
Drug ineffective
Emotional disorder
Enterocolitis haemorrhagic (bleeding and inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Epistaxis (bleed from the nose)
Gingival bleeding (bleeding gums)
Hemiparesis (weakness on one side of the body)
Multiple myeloma (cancer of the plasma cells)
Neurological symptom (symptoms of nervous system disease)

male:

Death
Joint swelling
Petechiae (a small red or purple spot caused by bleeding into the skin)
Platelet count decreased
Pyrexia (fever)
Oedema peripheral (superficial swelling)
Swelling face
Abdominal pain
Alanine aminotransferase increased
Aspartate aminotransferase increased

What are the common drug interactions of Promacta and Tenormin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Drug ineffective
Emotional disorder
Enterocolitis haemorrhagic (bleeding and inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Epistaxis (bleed from the nose)
Gingival bleeding (bleeding gums)
Hemiparesis (weakness on one side of the body)
Neurological symptom (symptoms of nervous system disease)
Speech disorder
Antimitochondrial antibody positive
Biliary cirrhosis primary (primary biliary cirrhosis (pbc) is a long-term liver disease that damages the small bile ducts in the liver. the build-up of bile damages the liver)

60+:

Bone marrow plasmacyte count increased
Bone marrow reticulin fibrosis (thickening and scarring of bone marrow reticulin)
Abdominal pain
Alanine aminotransferase increased
Aspartate aminotransferase increased
Drug ineffective
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Epistaxis (bleed from the nose)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Platelet count decreased

What are the existing conditions these people have? *

Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 8 people, 72.73%
Diabetes: 2 people, 18.18%
Thrombocytopenia (decrease of platelets in blood): 1 person, 9.09%
Sneezing: 1 person, 9.09%
Rhinorrhea (watery mucus discharge from the nose): 1 person, 9.09%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 9.09%
Neuralgia (pain in one or more nerves): 1 person, 9.09%
Itching: 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%
High Blood Cholesterol: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Promacta and Tenormin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously